- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05090670
The Impact of Germanium-Embedded Knee Brace on Patient Recovery After Knee Arthroscopy
The Impact of Germanium-Embedded Knee Brace on Patient Recovery After Knee Arthroscopy: a Blinded and Randomized Controlled Trial
Anti-inflammatory brace technology has demonstrated superior clinical outcomes in the management of knee osteoarthritis and accelerate recovery time for Major League Soccer players. Authors have postulated that embedding germanium into cotton garments increases circulation and augments the inflammatory process through a transdermal micro-electromagnetic field. In addition to immunomodulatory effects, knee braces immobilize and stabilize the joint through tactile feedback from the skin. Thus, a germanium-embedded knee brace may provide inflammatory control to augment pain and edema while concomitantly enhancing proprioception. Knee Arthroscopy rehabilitation goals during the acute post-operative phase include diminishment of pain and edema as well as restoration of knee range-of-motion. The presented study intends to assess the impact of a germanium-embedded knee brace on patient recovery after Knee Arthroscopy.
Single-center blinded randomized controlled clinical trial to study effectiveness of germanium-infused knee brace on rehabilitation in patient population undergoing Knee Arthroscopy. Patients will be randomized into germanium-infused knee brace group and compared to a replica knee brace group. Inclusion criteria will include skeletally mature individuals undergoing primary Knee Arthroscopy. Exclusion criteria will include autoimmune disorders and history of surgery on ipsilateral joint. The presented protocol intends to assess the impact of a germanium-embedded knee brace on patient recovery after Knee Arthroscopy. The primary outcome measure was chosen for its implications for the design and conduct of the study,1 including well-validated outcome instrument for comparison, facilitation of a priori power analysis, randomization, and blinding. Secondary outcomes were chosen for their pertinence to surgeon decision-making during patient rehabilitation.
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- 18-100 years old
- Male or female
- Compliant patient
- BMI less than 35
- Undergoing Knee Arthroscopy within 30 days
Exclusion Criteria:
- Rheumatoid Arthritis
- Poorly controlled diabetes (HgA1c > 7.5)
- Previous blood clots
- BMI greater than 35
- Varicosities on operative leg
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Germanium-Embedded Knee Brace
Following surgery the patients effected limb would be placed in an Germanium-Embedded Knee Brace
|
Germanium-Embedded Knee Brace will be applied to the effected limb following Knee Arthroscopy
|
|
ACTIVE_COMPARATOR: Replica Knee Brace
Following surgery the patients effected limb would be placed in a replica knee brace
|
Replica Knee brace will be applied to the effected limb following Knee Arthroscopy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Short Form 36 (SF-36)
Time Frame: 4 weeks
|
A well-validated patient reported outcome and the most commonly used outcome instrument in orthopaedics.
|
4 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Leg Circumference
Time Frame: 6 weeks
|
In centimeters, measure by senior surgeon during physical exam using a tape measure at standard post-operative visits
|
6 weeks
|
|
Knee Range of Motion
Time Frame: 6 weeks
|
In degrees, measured by a senior surgeon using a Goniometer, at standard post-operative visits
|
6 weeks
|
|
Pain Estimation
Time Frame: 6 weeks
|
Visual Analog Scale, minimum is 0, maximum is 10 and median is 5
|
6 weeks
|
Collaborators and Investigators
Collaborators
Study record dates
Study Major Dates
Study Start (ANTICIPATED)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IW002
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Knee Arthroscopy
-
University Hospital, Strasbourg, FranceRecruiting
-
Peking University Third HospitalCompleted
-
Sheba Medical CenterWithdrawn
-
University Hospital, Strasbourg, FranceRecruiting
-
Mansoura UniversityCompleted
-
University Health Network, TorontoCompleted
-
The Cleveland ClinicTerminatedKnee ArthroscopyUnited States
-
Hospital for Special Surgery, New YorkTerminated
-
Centre Hospitalier Universitaire Saint PierreHôpital de Braine-l'AlleudCompleted
Clinical Trials on Incrediwear Germanium-Embedded Knee Brace following Knee Arthroscopy
-
Total Sports Medicine & OrthopedicsNot yet recruitingAnterior Cruciate Ligament Injuries